Answer
Torisel (temsirolimus) is indicated as first-line treatment for adults with advanced renal cell carcinoma who have at least three of six prognostic risk factors.
Sources for this answer
- TORISEL 30 mg concentrate and solvent for solution for infusionPfizer Limited · emc · SmPC §4.1 Therapeutic Indications · Version 33Document updated
Sources checked